Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Atrial Fibrillation
Interventions
DEVICE

Implantable Cardiac Monitor (Confirm ICM model 2102)

Patients who meet the study criteria will be implanted with a St. Jude Medical Confirm Implantable Cardiac Monitor (Confirm ICM) model 2102 or other St. Jude Medical ICM with the same capabilities.

Trial Locations (19)

T2N 2T9

University of Calgary, Calgary

R2H 2A6

St. Boniface Hospital, Winnepeg

B3H 3A7

Queen Elizabeth-II Heather Sciences Center, Halifax

P3E 5J1

Health Sciences North, Greater Sudbury

L8L 2X2

Hamilton Health Sciences - Electrophysiology Clinic, Hamilton

Hamilton Health Sciences - Interventional Cardiology, Hamilton

Hamilton Health Sciences - Perioperative Ischemia Research Group, Hamilton

N6A 5A5

London Health Sciences Center University Hospital, London

L3Y 2P9

Southlake Regional HealthCare, Newmarket

613-761-5208

University of Ottawa Heart Institute, Ottawa

M5G 2C4

University Health Network, Toronto

H9S 1H4

McGill University Health Centre, Montreal

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Quebec (Hopital Laval), Sainte-Foy

1100 DD

Academisch Medisch Centrum (AMC) Amsterdam, Amsterdam

4818 CK

Amphia Hospital, Breda

9202 DA

Nij Smellinge, Drachten

2803 HH

Groene Hart Ziekenhuis Gouda, Gouda

2334 CK

Diakonessenhuis Leiden, Leiden

3083 AN

Ikazia Hospital, Rotterdam

All Listed Sponsors
collaborator

Abbott Medical Devices

INDUSTRY

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Population Health Research Institute

OTHER

NCT01694394 - Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor | Biotech Hunter | Biotech Hunter